RK
Rohit Kumar Barnwal
About Rohit Kumar Barnwal
Data last updated:
Rohit Kumar Barnwal has 14 years in corporate governance. Holds Director role. Currently with 2 companies, including Evitalife Science Private Limited and Evitalife Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Evitalife Pharma Private Limited at ₹5.68 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Jan 2012 | 2012 | ₹5.68 Cr (FY 2024) | Active | |
| Director | 11 Feb 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rohit Kumar Barnwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rohit Kumar Barnwal
Rohit Kumar Barnwal has 14 years in corporate governance. Holds Director role. Currently with 2 companies, including Evitalife Science Private Limited and Evitalife Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Evitalife Pharma Private Limited at ₹5.68 Cr (FY 2024).
Rohit Kumar Barnwal is associated with 2 companies as Director, including Evitalife Pharma Private Limited (₹5.68 Cr), Evitalife Science Private Limited.
Rohit Kumar Barnwal has expertise in General Business.
Rohit Kumar Barnwal has 14 years in corporate governance.
By reported revenue, the largest current company of Rohit Kumar Barnwal is Evitalife Pharma Private Limited, with revenue of ₹5.68 Cr (FY 2024).
Rohit Kumar Barnwal currently holds positions at 2 companies: Evitalife Pharma Private Limited (₹5.68 Cr), Evitalife Science Private Limited.